NCT06084572

Brief Summary

Commonly, in clinical practice an automated analysis of pH-MII tracings is obtained.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2023

Typical duration for all trials

Geographic Reach
2 countries

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 29, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 2, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 16, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 19, 2025

Status Verified

March 1, 2025

Enrollment Period

2.5 years

First QC Date

October 2, 2023

Last Update Submit

March 13, 2025

Conditions

Keywords

GERDpH-impedanceWingate-consensusLyon consensus

Outcome Measures

Primary Outcomes (1)

  • Statistical difference in the GERD categorisation

    the statistical difference in the distribution of GERD categorisation between automated vs. manual review of the pH-MII tracings

    During baseline visit

Secondary Outcomes (8)

  • The analysis of the influence of different parameters on application of the Wingate criteria: including the Indication for referral with further classification into predominant oesophageal and extra-oesophageal symptoms;

    During baseline visit

  • The analysis of the influence of different parameters on application of the Wingate criteria: including the GERD Symptom Severity;

    During baseline visit

  • The analysis of the influence of different parameters on application of the Wingate criteria: including the patient being on or off PPI;

    During baseline visit

  • The analysis of the influence of different parameters on application of the Wingate criteria: including MNBI (obtained by automated analysis or manually calculated);

    During baseline visit

  • Presence of significant correlations between censored episodes and pH-MII parameters

    During baseline visit

  • +3 more secondary outcomes

Study Arms (1)

GERD patients

Other: Questionnaires

Interventions

FSSG \& BEDQ

GERD patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients referred for pH-MII are eligible.

You may qualify if:

  • Adult patients aged 18 - 80 years old;
  • pH-MII performed off PPI

You may not qualify if:

  • Prior upper GI endoscopy indicative of structural disease (except for oesophagitis or hiatal hernia).
  • Incomplete pH-MII (less than 21 hours recording);
  • Ph-MII performed on PPI
  • Suboptimal quality of the tracings preventing interpretation in clinical practice;
  • Prior oesophageal (including anti-reflux intervention) or gastric surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

H.U.B

Anderlecht, 1080, Belgium

RECRUITING

UZ Brussel

Jette, 1090, Belgium

RECRUITING

Technische Universität München

München, 81675, Germany

RECRUITING

MeSH Terms

Conditions

Gastroesophageal Reflux

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Sébastien Kindt, Prof. Dr.

CONTACT

Virgini Van Buggenhout

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2023

First Posted

October 16, 2023

Study Start

September 29, 2023

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

March 19, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations